These results suggested that interfering CASC9 might inhibit ESCC growth by reducing cell proliferating rate and blocking cell cycle rather than promoting cell apoptosis, indicating its possible involvement in cell cycle regulation. Here, CASC9 is linked to esophageal squamous cell carcinoma.